A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

Recruiting

Phase 2

BFF with MDIA Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

Sponsor:

AstraZeneca

Code:

NCT07525375

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 4 - 11

Healthy Volunteers: Not accepted

Interventions

GP MDI

BFF MDI

Placebo MDI

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-20. This information was provided to ClinicalTrials.gov by AstraZeneca on 2026-04-22.